Analysts are adjusting their Q1 2025 earnings forecasts for several companies, including Workiva, Titan International, Expro Group, Zimmer Biomet, and Zevia PBC. Also, IFP Advisors Inc. reduced its stake in Norwegian Cruise Line Holdings Ltd. Read more...

Desjardins analysts have released earnings forecasts for Quebecor and Skeena Resources. Quebecor is projected to earn $0.74 per share in Q1 2025, while Skeena Resources is expected to post a loss of ($1.10) per share for FY2024. Read more...

A quick look at recent stock market activity, including analyst ratings updates for Vera Therapeutics, RF Industries, and United Therapeutics, plus short interest fluctuations in MingZhu Logistics and XOMA Co. Read more...

Analyst updates include lowered EPS estimates for Epsilon Energy (EPSN) by Roth Capital, reduced holdings in Vanguard Mortgage-Backed Securities ETF (VMBS) by IFP Advisors, FY2029 EPS estimates for Schrödinger (SDGR) by Leerink Partnrs, and Q1 2025 earnings estimates for Trulieve Cannabis (TRU) by Roth Capital. Read more...

B. Riley adjusts estimates for several companies, including upgrading New York Mortgage Trust, forecasting UMH Properties' Q1 earnings, and revising earnings per share for Montauk Renewables and Ameresco. Read more...

A look at upcoming earnings reports from several companies including Hycroft Mining, IN8bio, Paltalk, and Weibo, along with updates on Novavax and The Hackett Group. Read more...

A look at key business trends, from CD Projekt's comeback to concerns over UnitedHealth's growth and the continued popularity of VGT, despite high valuations. Read more...

Zacks Research has released a flurry of updated earnings per share (EPS) estimates for various companies for Q1 2025, impacting firms across diverse sectors. Read more...

Bell Media announces layoffs while assuring no impact on news programs. Meanwhile, Toro reports a mixed Q1 2025 with strong EPS but weaker revenue. Read more...

Fubo TV reports subscriber and revenue growth despite ongoing losses, as a potential Disney merger with Hulu + Live TV approaches. Warner Bros. Discovery faces earnings concerns. Read more...

Zscaler's AI-driven growth, Burlington Stores' earnings beat, and analyst adjustments for Ready Capital are among the key market movers. Plus, a strategy for passive income. Read more...

Analysts issue earnings forecasts for SBC Medical, Nuvalent, and Intrusion, while OptimumBank prepares to announce quarterly results. Logitech announces a share buyback program. Read more...

A summary of recent business news, including an Italian tax investigation into Elon Musk and updates on several companies' stock ratings and earnings estimates. Read more...

Recent analyst activity includes a buy rating for Jamf and lowered earnings estimates for Fortrea, Verisk, Teladoc Health, and VSE, all involving insights from William Blair. CentralReach is also exploring a sale with William Blair's assistance. Read more...

Recent analyst reports show a mixed outlook for companies like Chegg, MasTec, Mohawk Industries, Titan International, and Butterfly Network, with ratings ranging from "Reduce" to increased investment. Read more...

Apple is making big moves in AI, including expanded language support for Apple Intelligence, AI-powered app review summaries, and a custom 5G modem for the iPhone 16e. Plus, is the new Mac Studio worth the upgrade? Read more...

This week's business news includes International Women's Day celebrations, mattress reviews for 2025, and analyst predictions for Q1 earnings from Standard Motor Products and Syndax Pharmaceuticals. Read more...

In Spain, families are donating unprecedented sums to help their children purchase homes, evidenced by a record number of property transfers in 2024. Earnings call transcripts from major corporations are also in focus. Read more...

Praxis faces a complex investment landscape. Despite a "Hold" rating and setbacks with Ulixacaltamide, the company presents a high-risk, high-reward opportunity in the epilepsy sector. Read more...

Recent reports show mixed performance for tech stocks. Nvidia faces headwinds, while BioVie and Bel Fuse see increased short interest. Olaplex maintains its rating. Read more...